A
$ Value
$0
Shares
8,759
Price
$0
Filed
May 23
Insider
Name
Howell Peyton R
Title
—
CIK
0001528056
Roles
Director
Transaction Details
Transaction Date
2025-05-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
8,759
Footnotes
Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). | Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. | RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. | Awarded on May 21, 2025 pursuant to the 2023 Plan.
Filing Info
Howell Peyton R's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-05-22 | TNDM | M | $91K |
| 2025-05-22 | TNDM | M | $0 |
| 2025-05-21 | TNDM | A | $0 |
Other Insiders at TNDM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sheridan John F
PRESIDENT & CEO
|
— | — | 2026-02-17 |
|
Carpenter Rick
Chief Technology Officer
|
— | — | 2026-02-17 |
|
Morrison Susan
EVP & Chief Admin. Officer
|
— | — | 2026-02-17 |
|
Vosseller Leigh
EVP & CHIEF FINANCIAL OFFICER
|
— | — | 2026-02-17 |
|
Kyrillos Jean-Claude
EVP & Chief Operating Officer
|
— | — | 2026-04-15 |
|
Gasser Elizabeth Anne
EVP, Chief Strategy Officer
|
— | — | 2026-02-17 |
|
Hansen Shannon Marie
EVP & Chief Legal Officer
|
— | — | 2026-02-17 |
|
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
|
— | $4K | 2026-03-17 |